Penn Medicine 2020 Updates in Oncology
Video Player is loading.
10 seconds
Playback speed
2020 ASCO Update on Prostate Cancer: How Effective Are Recently FDA Approved Olaparib & Rucaparib for mCRPC With HRR-gene Defects? Does a Novel GnRH Antagonist Relugolix Look Promising?
By
Penn Medicine 2020 Updates in Oncology
FEATURING
Vivek Narayan
By
Penn Medicine 2020 Updates in Oncology
FEATURING
Vivek Narayan
Comments 0
Login to view comments.
Click here to Login
